Fidson Commences Study Of WHO Prequalification For Albendazole Drug

...Says approval could be ready in 18 months Fidson Healthcare Plc, Nigeria’s foremost pharmaceutical company has announced a strategic partnership with Liddie BE Ltd, a renowned Clinical Research Organisation, to conduct a Bioequivalence (BE) study on their chewable formulation of Albendazole tablets. The Founder and CEO of Fidson Healthcare Plc, Dr Fidelis Ayebae who announced...The post Fidson Commences Study Of WHO Prequalification For Albendazole Drug first appeared on New Telegraph.The post Fidson Commences Study Of WHO Prequalification For Albendazole Drug appeared first on New Telegraph.

Read More